Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...

Lupin receives US FDA approval for sacubitril and valsartan tablets: Our Bureau, Mumbai Friday, January 24, 2025, 15:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announc ...

Reuters Nifty continues to climb a wall of worry as it looks to be in the final leg of its rally before heading for a ...

Lupin Ltd share price was down by -0.79% from the previous closing price of ₹2,151.20. Who are peers of Lupin Ltd? The peers of Lupin Ltd are Sun Pharmaceuticals Industries Ltd, Divis ...

Shares of Lupin Ltd surged 2.38 per cent to ₹2,364.65 on the BSE at 11.27 AM and it reached an all-time high of ₹2,372.55 during the session. Lupin Ltd., a global pharmaceutical company ...

AM (IST) on Wednesday, 0.62 per cent from previous close. The stock quoted a 52-week low price of Rs 1411.15 and a high of Rs ...

Global pharma major Lupin Limited on Thursday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ...

Global pharma major Lupin Limited on Monday announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio. According to the company ...

Photo Credit: vitapix Drugmaker Lupin Ltd has acquired Huminsulin in India from Eli Lilly and Company, for an undisclosed amount. The move will strengthen Lupin’s diabetes footprint in the country.